News

Medigene Reports Results for the First Half of 2018

SHOW RELEASE

Medigene presents at upcoming conferences

SHOW RELEASE

Medigene CEO Dolores Schendel Receives Bavarian Order of Merit

SHOW RELEASE

Medigene presents at five upcoming conferences

SHOW RELEASE

Medigene successfully raises EUR 32.3 million in oversubscribed private placement

SHOW RELEASE

Medigene announces capital increase to fund immunotherapy programs

SHOW RELEASE

Medigene reports outcome of Annual General Meeting

SHOW RELEASE

Medigene significantly expands TCR alliance with bluebird bio in cancer immunotherapy

SHOW RELEASE

Medigene AG reports First Quarter 2018 financials and provides operational update

SHOW RELEASE

Medigene's Academic Partners Provide Update on Planned MAGE-A1-specific TCR Clinical IIT during CIMT

SHOW RELEASE

Medigene presents data on the successful production of AML DC vaccines at AACR conference

SHOW RELEASE

Medigene participates at five upcoming conferences

SHOW RELEASE

Clinical data for DC vaccine in prostate cancer IIT study presented by Oslo University

SHOW RELEASE

Medigene appoints Dr. Kai Pinkernell to the Executive Management Board as CMO/CDO

SHOW RELEASE

Medigene publishes 2017 annual report and announces start of clinical trial with TCR immunotherapy MDG1011

SHOW RELEASE